IP Library Granted Patent US 8,628,514
Granted Patent B2
US 8,628,514 · App. 13/144,304 · Granted Jan 14, 2014

Multi-dose medical fluid injection system having patient-specific tubing set with use indicator

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,628,514
App. No.
13/144,304
Granted
Jan 14, 2014
Kind
B2
Abstract

A single-use, single-patient, or patient-specific tubing set ( 300 ) is disclosed. The tubing set ( 300 ) includes at least one check valve ( 304 ), along with a use indicator ( 320 ). This use indicator ( 320 ) provides a visual indication when the tubing set ( 300 ) has been used for an injection. In this regard, a piston ( 340 ) moves from one position to another when exposed to a certain fluid pressure.

Claims (33)

1. A medical fluid injection system, comprising:

an injection device;

a multi-patient tubing set interconnected with said injection device; and

a patient-specific tubing set interconnected with said multi-patient tubing set, wherein said patient-specific tubing set comprises:

at least one valve;

a use indicator movable from a first position to a second position in response to a force exerted on said use indicator by flow through said patient-specific tubing set; and

a lock, wherein said use indicator is retained in said second position by said lock upon being moved from said first position to said second position to visually convey that said patient-specific tubing set has been used in an injection by operation of said injection device.

2. A medical fluid injection system, comprising:

an injection device;

a multi-patient tubing set interconnected with said injection device; and

a patient-specific tubing set interconnected with said multi-patient tubing set, wherein said patient-specific tubing set comprises:

at least one valve;

a use indicator, wherein said use indicator comprises a housing and a piston movably disposed within said housing, and wherein said piston interfaces with a flowpath through said housing; and

a lock, wherein said piston moves in response to a force exerted on said piston by a flow through said flowpath to a position that visually conveys that said patient-specific tubing set has been used in an injection by operation of said injection device, and is thereafter retained in said position by said lock.

3. The system of claim 2 , wherein said use indicator comprises a pop-out indicator.

4. The system of claim 2 , wherein said piston is movable from a first position to a second position in response to exposure to at least a certain pressure within said flowpath.

5. The system of claim 2 , wherein said injection device comprises a power injector having a syringe mounted thereto, wherein said multi-patient tubing set is detachably interconnected with said syringe.

6. The system of claim 2 , wherein said at least one valve comprises first and second valves disposed along a flowpath of said patient-specific tubing set.

7. The system of claim 6 , wherein said first and second valves comprise first and second check valves, respectively.

8. The system of claim 2 , wherein said at least one valve comprises a check valve.

9. The system of claim 2 , wherein said piston is movable from a first position to a second position in response to flow through said patient-specific tubing set.

10. The system of claim 9 , wherein said piston being in said second position is indicative of a previous use of said patient-specific tubing set.

11. The system of claim 9 , wherein said piston is retained by said lock in said second position upon being moved from said first position to said second position.

12. The system of claim 9 , wherein a minimum pressure of 15 psi is required to move said piston from said first position to said second position.

13. The system of claim 9 , wherein said piston is directed into an open space when moved from said first position to said second position and continues to interface with said open space when in said second position.

14. The system of claim 9 , wherein said piston moves axially from said first position to said second position in response to development of at least a certain fluid pressure within said flowpath.

15. The system of claim 9 , wherein said housing comprises a detent that restrains said piston when moved into said second position, wherein said lock comprises said detent.

16. The system of claim 9 , wherein said piston extends beyond said housing when in said second position.

17. The system of claim 2 , wherein said piston moves along a path that is orthogonal to a direction of a fluid passing through said flowpath.

18. The system of claim 2 , wherein said patient-specific tubing set comprises first and second connectors on opposite ends thereof.

19. The system of claim 2 , further comprising a fluid source fluidly interconnected with said injection device.

20. The system of claim 19 , wherein said fluid source comprises a volume of fluid that accommodates multiple injections by said injection device.

21. The system of claim 2 , wherein said patient specific tubing set is detachably interconnected with said multi-patient tubing set.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2011
From: FAGO, FRANK M.
To: MALLINCKRODT INC.
Reel/Frame 026581/0856 →
CHANGE OF NAME Recorded Jul 13, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026582/0169 →